Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Fortification, folate and vitamin B12 balance, and the nervous system. Is folic acid excess potentially harmful?

Abstract

The benefits of folic acid fortification are well known but less understood or acknowledged is the growing evidence of potential harms to the nervous system from excess folate, primarily because of a combination of fortification and/or high and sustained intake of folic acid supplements. We have summarised the historical, clinical, epidemiological and experimental evidence accumulated over the last 60 years in the pre and postfortification eras, which consistently and substantially suggests that excess folate, in particular in folic acid users, can have direct harms to the nervous system, especially in the presence of vitamin B12 deficiency. The harms are related both to the dose and duration of exposure to excess folic acid. Recent experimental evidence suggests that impaired cortical neurogenesis with excess folic acid is similar to that of folate or vitamin B12 deficiency and greatest when folate excess is present with vitamin B12 deficiency. Excess folate leads to a fall in vitamin B12 levels and aggravation of the block in folate metabolism resulting from vitamin B12 deficiency. The balance between folate and vitamin B12 is crucial to the functioning of one carbon metabolic pathways, the methylation cycle and ultimately to DNA and RNA structure and function, genetic and epigenetic stability. Vitamin B12 deficiency is an independent risk factor for NTDs and accounts for the increased risk of NTDs in some countries where B12 deficiency is more common than folate deficiency. A more prudent and balanced approach to fortification with folic acid, or preferably a natural reduced folate, combined with vitamin B12 would potentially improve the benefits and reduce the harms, including epigenetic and transgenerational risks, associated with current public health policies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Relationships between the folate cycle, vitamin B12, nucleotide synthesis and the methylation cycle.

Similar content being viewed by others

Data availability

This is a review, and all data in this article were from published articles.

References

  1. Botez MI, Reynolds EH, editors. Folic acid in neurology, psychiatry and internal medicine. New York: Raven Press; 1979.

  2. Reynolds E. Vitamin B12, folic acid and the nervous system. Lancet Neurol. 2006;5:949–60.

    CAS  PubMed  Google Scholar 

  3. Green R, Allen LH, Bjorke-Monsen AL, Brito A, Guéant JL, Miller JW, et al. Vitamin B12 deficiency. Nat Rev Dis Prim. 2017;3:17046.

    Google Scholar 

  4. MRC Vitamin Study Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131–7.

    Google Scholar 

  5. Massaro EJ, Rogers JM, editors. Folate and human development. Totowa, New Jersey: Humana Press; 2002.

  6. Mills JL, Molloy AM, Reynolds EH. Do the benefits of folic and fortification outweigh the risk of masking vitamin B12 deficiency?. BMJ. 2018;360:p724.

    Google Scholar 

  7. Crider KS, Qi YP, Yeung LF, Mai CT, Zauche LH, Wang A, et al. Folic acid and the prevention of birth defects; 30 years of opportunity and controversies. Annu Rev Nutr. 2022;42:423–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Food and Drug Administration. Food labelling: health claims and label statements; Folate and neural tube defects. Federal Register. 1993;58:53254–70.

    Google Scholar 

  9. Institute of Medicine. Dietary references intakes for thiamine, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC, USA; National Academy Press; 1998, pp. 196–305.

  10. Reynolds EH. What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies. Eur J Clin Nutr. 2016;70:537–40.

    CAS  PubMed  Google Scholar 

  11. Wald NJ, Morris JK, Blakemore C. Public Health failure in the prevention of neural tube defects: time to abandon the tolerable upper intake level of folate. Public Health Rev. 2018;39:2. https://doi.org/10.1186/s40985-018-00796.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Wald NJ. Folic acid and neural tube defects: discovery, debate and the need for policy change. J Med Screen. 2022;29:138–46. https://doi.org/10.1177/09691413221102321.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Morris JK, Wald NJ. Fully effective folic acid fortification. JAMA. 2023;330:417–8.

    PubMed  Google Scholar 

  14. Looi MK. The case to rethink the U.K.’s food fortification plans. BMJ. 2023;381:1158.

    PubMed  Google Scholar 

  15. Reynolds EH. Neurological aspects of folate and vitamin B12 metabolism. In: Hoffbrand AV, editor. Clinics in Haematology, Vol. 5. London: Saunders; 1976, pp. 661–96.

  16. Will JJ, Mueller JF, Brodine C, Kiely CE, Friedman B, Hawkins VR, et al. Folic acid and vitamin B12 in pernicious anaemia: studies on patients treated with these substances over a ten year period. J Lab Clin Med. 1959;53:22–38.

    CAS  PubMed  Google Scholar 

  17. Schwartz SO, Kaplan SR, Artmstrong BE. The long term evaluation of folic acid in the treatment of pernicious anaemia. J Lab Clin Med. 1950;35:894–8.

    CAS  PubMed  Google Scholar 

  18. Lear AA, Castle WB. Supplemental folic acid therapy in pernicious anaemia: the effect on erythropoiesis and serum vitamin B12 concentrations in selected cases. J Lab Clin Med. 1956;47:88–97.

    CAS  PubMed  Google Scholar 

  19. Bok J, Faber JG, de Vries JA, Kroese WF, Nieweg HO. The effect of pteroylglutamic acid administration on the serum vitamin B12 concentrations in pernicious anaemia in relapse. J Lab Clin Med. 1958;51:667–71.

    CAS  PubMed  Google Scholar 

  20. Hunter R, Barnes J, Matthews DM. The effect of folic acid supplement on serum vitamin B12 levels in patients on anticonvulsants. Lancet. 1969;2:666–7.

    CAS  PubMed  Google Scholar 

  21. Reynolds EH, Wrighton RJ, Johnson AL, Preece J, Chanarin I. Inter-relations of folic acid and vitamin B12 in drug-treated epileptic patients. Epilepsia. 1971;12:165–71.

    CAS  PubMed  Google Scholar 

  22. Selhub J, Miller JW, Troen AM, Mason JB, Jacques PF. Perspective: the high-folate-low-vitamin B12 interaction is a novel cause of vitamin B12 depletion with a specific aetiology- a hypothesis. Adv Nutr. 2022;13:16–33.

    CAS  PubMed  Google Scholar 

  23. Waters AH, Mollin DL. Studies on the folic acid activity of human serum. J Clin Pathol. 1961;14:335–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Reynolds EH. Inter-relationships between the neurology of folate and vitamin B12 metabolism. In: Botez MI, Reynolds EH, editors. Folic acid in neurology, psychiatry and internal medicine. New York: Raven Press; 1979. pp. 501–515.

  25. Oussalah A, Julien M, Levy J, Hajjar O, Franczak C, Stephan C, et al. Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis. J Clin Med. 2019;8:551.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Agamanolis DP, Chester EM, Victor M, Kark JA, Hines JD, Harris JW. Neuropathology of experimental vitamin B12 deficiency in monkeys. Neurology. 1976;26:905–14.

    CAS  PubMed  Google Scholar 

  27. Van der Westhuvzen J, Fernandes-Costa F, Metz J. Cobalamin inactivation by nitrous oxide produces severe neurological impairment in fruit bats: protection by methionine and aggravation by folates. Life Sci. 1982;31:2001–10.

    Google Scholar 

  28. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B12 status in relation to anaemia, macrocytosis and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr. 2007;85:193–200.

    CAS  PubMed  Google Scholar 

  29. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in anaemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr. 2010;91:1733–44.

    CAS  PubMed  Google Scholar 

  30. Selhub J, Morris MS, Jacques PF, Rosenberg IH. Folate-vitamin B12 interaction in relation to cognitive impairment, anaemia and biochemical indicators of vitamin B12 deficiency. Am J Clin Nutr. 2009;89:7025–6.

    Google Scholar 

  31. Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, et al. Homocysteine, vitamin B12 and folic acid levels in Alzheimer’s disease, mild cognitive impairment and healthy elderly: baseline characteristics in subjects of the Australian imaging biomarker lifestyle study. J Alzheimers Dis. 2011;27:909–22.

    CAS  PubMed  Google Scholar 

  32. Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, et al. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from 3 cohorts. J Alzheimers Dis. 2014;39:661–8.

    CAS  PubMed  Google Scholar 

  33. Morris MS, Selhub J, Jacques PF. Vitamin B12 and folate status in relation to decline in scores on the mini-mental state examination in the Framlingham Heart Study. J Am Geriatr Soc. 2012;60:1457–64.

    PubMed  PubMed Central  Google Scholar 

  34. Bailey RL, Jun S, Murphy L, Green R, Gahche JJ, Dwyer JT, et al. High folic acid or folate combined with low vitamin B12 status: potential but inconsistent association with cognitive function in a nationally representative cross-sectional sample of US older adults participating in the NHANES. Am J Clin Nutr. 2020. https://doi.org/10.1093/ajcn/nqaa239.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Miller JW, Garrod MG, Allen LA, Haan MN, Green R. Metabolic evidence of vitamin B12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate. Am J Clin Nutr. 2009;90:1586–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Brito A, Verdugo R, Hertrampf E, Miller JW, Green R, Fedosov SN, et al. Vitamin B12 treatment of asymptomatic, deficient, elderly Chileans improves conductivity in myelinated peripheral nerves, but high serum folate impairs vitamin B12 status response assessed by the combined indicator of vitamin B12 status. Am J Clin Nutr. 2016;103:250–7.

    CAS  PubMed  Google Scholar 

  37. Valera-Gran D, Navarrete-Munoz EM, Garcia de la Hera M, Fernández-Somoano A, Tardón A, Ibarluzea J, et al. Effect of maternal high dosages of folic acid supplements on neurocognitive development in children at 4-5 years of age: the prospective birth cohort Infancia y Medio Ambiente (INMA) study. Am J Clin Nutr. 2017. https://doi.org/10.3945/ajcn.117.152769.

    Article  PubMed  Google Scholar 

  38. Miller JW, Smith A, Troen AM, Mason JB, Jacques PF, Selhub J. Excess folic acid and vitamin B12 deficiency: clinical implications?. Food Nutr Bull. 2024;45:S67–S72.

    PubMed  PubMed Central  Google Scholar 

  39. Bahous RH, Jadqavji NM, Deng L, Cosin-Tomas M, Lu J, Malysheva O, et al. High dietary folate in pregnant mice leads to pseudo-MTHFR deficiency and altered methyl metabolism, with embryonic growth delay and short term memory impairment in offspring. Human Mol Genet. 2017;26:888–900.

    CAS  Google Scholar 

  40. De Crescenzo AH, Panoutsopoulos AA, Tatt L, Schaaf Z, Racherla S, Henderson L, et al. Deficient or excess folic acid supply during pregnancy alter cortical neurodevelopment in mouse offspring. Cerebral Cortex. 2020;31:635–49.

  41. Tatt L, Cannizzaro N, Schaaff Z, Racherla S, Bottiglieri T, Green R, et al. Prenatal folic acid and vitamin B12 imbalance alter neuronal morphology and synaptic density in the mouse neocortex. Commun Biol. 2023;6:1123.

  42. Luan Y, Cosin-Tomas M, Leclerc D, Malysheva O, Caudill MA, Rozen R. Moderate folic acid supplementation in pregnant mice results in altered sex-specific gene expression in brain of young mice and embryos. Nutrients. 2022;14:1051.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Cao X, Xu J, Lin YL, Cabrera RM, Chen Q, Zhang C, et al. Excess folic acid intake increases DNA de novo point mutations. Cell Discov. 2023;9:22.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Lucock M, Yates Z. Folic acid- vitamin and panacea or genetic timebomb?. Nature Rev Genet. 2005;6:235.

    CAS  PubMed  Google Scholar 

  45. Godbole K, Deshmukh U, Yajnik C. Neutrigenetic determinants of neural tube defects in India. Indian Paediatr. 2009;46:467–75.

    Google Scholar 

  46. Sawaengsri H, Bergethon PR, Qiu WQ, Scott TM, Jacques PF, Selhub J, et al. Transcobalamin 776C->G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake. Am J Clin Nutr. 2016;104:1665–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Cornet D, Clement A, Clement P, Menezo Y. High doses of folic acid induce a pseudo-methylenetetrahydrofolate syndrome. Sage Open Med Case Rep. 2019;7:1–4.

    Google Scholar 

  48. Iskandar PJ, Rizk E, Meier B, Hariharan N, Bottiglieri T, Finnell RH, et al. Folate regulation of axonal regeneration in the rodent central and nervous system through DNA methylation. J Clin Invest. 2010;120:1603–16.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Patel NJ, Hogan KJ, Rizk E, Stewart K, Madrid A, Meethal SV, et al. Ancestral folate promotes neuronal regeneration in serial generations of progeny. Mol Neurobiol. 2020;57:2048–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. Ray JG, Wyatt PR, Thompson MD, Vermeulen MJ, Meier C, Wong P-Y, et al. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology. 2007;18:362–6.

    PubMed  Google Scholar 

  51. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Paediatrics. 2009;123:917–23.

    Google Scholar 

  52. Finkelstein JL, Fothergill A, Johnson CB, Guetterman HM, Bose B, Jabbar S, et al. Anaemia and vitamin B12 and folate status in women of reproductive age in Southern India: estimating population-based risk of neural tube defects. Curr Dev Nutr. 2021;5:nzabO69.

    Google Scholar 

  53. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, Fisher DJ, et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia. 2007;51:29–38.

    PubMed  PubMed Central  Google Scholar 

  54. Behere RV, Yajnik CS. Low vitamin B12- High folate status in adolescence and pregnant women may have deleterious effects on health of the offspring. Am J Clin Nutr. 2021. https://doi.org/10.1093/ajcn/nqab007.

    Article  PubMed  Google Scholar 

  55. Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Bailliere’s Clin Haematol. 1995;8:657–78.

    CAS  Google Scholar 

  56. Ledowsky C, Mahimbo A, Scarf V, Steel A. Women taking a folic acid supplement in countries with mandatory food fortification programmes may be exceeding the upper tolerable limit of folic acid: a systematic review. Nutrients. 2022;14:2715. https://doi.org/10.3390/nu14132715.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Reynolds EH. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiat. 2002;72:567–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  58. Patel KR, Sobczynska-Malefora A. The adverse effects of an excessive folic acid intake. Eur J Clin Nutr. 2017;71:159–63.

    CAS  PubMed  Google Scholar 

  59. Akiyama T, Kuki I, Kim K, Yamamoto N, Yamada Y, Igarashi K, et al. Folic acid inhibits 5-methyltetrahydrofolate transport across the blood cerebrospinal fluid barrier: clinical biochemical data from 2 cases. JIMD Rep. 2022;63:529–35.

    PubMed  PubMed Central  Google Scholar 

  60. Boilson A, Staines A, Kelleher CC, Daley L, Shirley I, Shrivastava A, et al. Unmetabolized folic acid prevalence is widespread in the older Irish population despite the lack of a mandatory fortification programme Am J Clin Nutr. 2012;96:613–21.

Download references

Author information

Authors and Affiliations

Authors

Contributions

The article was conceptualised and drafted by EHR. AS-M and RG added information, insights and edits. All authors approved the submitted version.

Corresponding author

Correspondence to Edward H. Reynolds.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

Since this study is a review, no ethical approval was required.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reynolds, E.H., Sobczyńska-Malefora, A. & Green, R. Fortification, folate and vitamin B12 balance, and the nervous system. Is folic acid excess potentially harmful?. Eur J Clin Nutr 79, 1073–1077 (2025). https://doi.org/10.1038/s41430-025-01652-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41430-025-01652-8

Search

Quick links